• レポートコード:GIR-2104Z06243 • 出版社/出版日:GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、107ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:化学・材料 |
Single User | ¥504,600 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥756,900 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、ガドブトロールのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ガドブトロールの種類別市場規模(単回投与バイアル(2 mL、7.5 mL、10 mL、15 mL)、単回投与プレフィルド注射(7.5 mL、10 mL、15 mL)、薬局バルクパッケージ(30mL、65mL))、用途別市場規模(成人、子供)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ガドブトロールの市場概要 ・企業情報(企業概要、製品概要、販売量、価格、売上):Bayer HealthCare Pharmaceuticals Inc.、SWAPNROOP DRUGS & PHARMACEUTICALS、Manus Aktteva Biopharma LLP、Jilin Tely Imp & Exp CO.,LTD、JinYan Chemicals (ShangHai) Co., Ltd.、BOC Sciences、LGM Pharma、Advanced Technology & Industrail Co., Ltd.、MedKoo Biosciences, Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年:単回投与バイアル(2 mL、7.5 mL、10 mL、15 mL)、単回投与プレフィルド注射(7.5 mL、10 mL、15 mL)、薬局バルクパッケージ(30mL、65mL) ・用途別分析2016年-2026年:成人、子供 ・ガドブトロールの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ ・ガドブトロールのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア ・ガドブトロールのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア ・ガドブトロールの南米市場規模2016年-2026年:ブラジル、アルゼンチン ・ガドブトロールの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Gadobutrol (CAS 138071-82-6) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Gadobutrol (CAS 138071-82-6) size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Gadobutrol (CAS 138071-82-6) market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Gadobutrol (CAS 138071-82-6) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
Single Dose Pre-filled Injections (7.5 mL, 10 mL, 15 mL)
Pharmacy Bulk Packages (30 mL and 65 mL)
Market segment by Application can be divided into
Adults
Children
The key market players for global Gadobutrol (CAS 138071-82-6) market are listed below:
Bayer HealthCare Pharmaceuticals Inc.
SWAPNROOP DRUGS & PHARMACEUTICALS
Manus Aktteva Biopharma LLP
Jilin Tely Imp & Exp CO.,LTD
JinYan Chemicals (ShangHai) Co., Ltd.
BOC Sciences
LGM Pharma
Advanced Technology & Industrail Co., Ltd.
MedKoo Biosciences, Inc.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Gadobutrol (CAS 138071-82-6) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gadobutrol (CAS 138071-82-6) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
1.2.3 Single Dose Pre-filled Injections (7.5 mL, 10 mL, 15 mL)
1.2.4 Pharmacy Bulk Packages (30 mL and 65 mL)
1.3 Market Analysis by Application
1.3.1 Overview: Global Gadobutrol (CAS 138071-82-6) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Adults
1.3.3 Children
1.4 Global Gadobutrol (CAS 138071-82-6) Market Size & Forecast
1.4.1 Global Gadobutrol (CAS 138071-82-6) Sales in Value (2016-2026))
1.4.2 Global Gadobutrol (CAS 138071-82-6) Sales in Volume (2016-2026)
1.4.3 Global Gadobutrol (CAS 138071-82-6) Price by Type (2016-2026) & (USD/MT)
1.5 Global Gadobutrol (CAS 138071-82-6) Production Capacity Analysis
1.5.1 Global Gadobutrol (CAS 138071-82-6) Total Production Capacity (2016-2026)
1.5.2 Global Gadobutrol (CAS 138071-82-6) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gadobutrol (CAS 138071-82-6) Market Drivers
1.6.2 Gadobutrol (CAS 138071-82-6) Market Restraints
1.6.3 Gadobutrol (CAS 138071-82-6) Trends Analysis
2 Manufacturers Profiles
2.1 Bayer HealthCare Pharmaceuticals Inc.
2.1.1 Bayer HealthCare Pharmaceuticals Inc. Details
2.1.2 Bayer HealthCare Pharmaceuticals Inc. Major Business
2.1.3 Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Product and Services
2.1.4 Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 SWAPNROOP DRUGS & PHARMACEUTICALS
2.2.1 SWAPNROOP DRUGS & PHARMACEUTICALS Details
2.2.2 SWAPNROOP DRUGS & PHARMACEUTICALS Major Business
2.2.3 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Product and Services
2.2.4 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Manus Aktteva Biopharma LLP
2.3.1 Manus Aktteva Biopharma LLP Details
2.3.2 Manus Aktteva Biopharma LLP Major Business
2.3.3 Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Product and Services
2.3.4 Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Jilin Tely Imp & Exp CO.,LTD
2.4.1 Jilin Tely Imp & Exp CO.,LTD Details
2.4.2 Jilin Tely Imp & Exp CO.,LTD Major Business
2.4.3 Jilin Tely Imp & Exp CO.,LTD Gadobutrol (CAS 138071-82-6) Product and Services
2.4.4 Jilin Tely Imp & Exp CO.,LTD Gadobutrol (CAS 138071-82-6) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 JinYan Chemicals (ShangHai) Co., Ltd.
2.5.1 JinYan Chemicals (ShangHai) Co., Ltd. Details
2.5.2 JinYan Chemicals (ShangHai) Co., Ltd. Major Business
2.5.3 JinYan Chemicals (ShangHai) Co., Ltd. Gadobutrol (CAS 138071-82-6) Product and Services
2.5.4 JinYan Chemicals (ShangHai) Co., Ltd. Gadobutrol (CAS 138071-82-6) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 BOC Sciences
2.6.1 BOC Sciences Details
2.6.2 BOC Sciences Major Business
2.6.3 BOC Sciences Gadobutrol (CAS 138071-82-6) Product and Services
2.6.4 BOC Sciences Gadobutrol (CAS 138071-82-6) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 LGM Pharma
2.7.1 LGM Pharma Details
2.7.2 LGM Pharma Major Business
2.7.3 LGM Pharma Gadobutrol (CAS 138071-82-6) Product and Services
2.7.4 LGM Pharma Gadobutrol (CAS 138071-82-6) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Advanced Technology & Industrail Co., Ltd.
2.8.1 Advanced Technology & Industrail Co., Ltd. Details
2.8.2 Advanced Technology & Industrail Co., Ltd. Major Business
2.8.3 Advanced Technology & Industrail Co., Ltd. Gadobutrol (CAS 138071-82-6) Product and Services
2.8.4 Advanced Technology & Industrail Co., Ltd. Gadobutrol (CAS 138071-82-6) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 MedKoo Biosciences, Inc.
2.9.1 MedKoo Biosciences, Inc. Details
2.9.2 MedKoo Biosciences, Inc. Major Business
2.9.3 MedKoo Biosciences, Inc. Gadobutrol (CAS 138071-82-6) Product and Services
2.9.4 MedKoo Biosciences, Inc. Gadobutrol (CAS 138071-82-6) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Gadobutrol (CAS 138071-82-6) Sales by Manufacturer
3.1 Global Gadobutrol (CAS 138071-82-6) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Gadobutrol (CAS 138071-82-6) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Gadobutrol (CAS 138071-82-6)
3.4 Market Concentration Rate
3.4.1 Top 3 Gadobutrol (CAS 138071-82-6) Manufacturer Market Share
3.4.2 Top 6 Gadobutrol (CAS 138071-82-6) Manufacturer Market Share
3.5 Global Gadobutrol (CAS 138071-82-6) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Gadobutrol (CAS 138071-82-6) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gadobutrol (CAS 138071-82-6) Market Size by Region
4.1.1 Global Gadobutrol (CAS 138071-82-6) Sales in Volume by Region (2016-2026)
4.1.2 Global Gadobutrol (CAS 138071-82-6) Revenue by Region (2016-2026)
4.2 North America Gadobutrol (CAS 138071-82-6) Revenue (2016-2026)
4.3 Europe Gadobutrol (CAS 138071-82-6) Revenue (2016-2026)
4.4 Asia-Pacific Gadobutrol (CAS 138071-82-6) Revenue (2016-2026)
4.5 South America Gadobutrol (CAS 138071-82-6) Revenue (2016-2026)
4.6 Middle East and Africa Gadobutrol (CAS 138071-82-6) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Gadobutrol (CAS 138071-82-6) Sales in Volume by Type (2016-2026)
5.2 Global Gadobutrol (CAS 138071-82-6) Revenue by Type (2016-2026)
5.3 Global Gadobutrol (CAS 138071-82-6) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Gadobutrol (CAS 138071-82-6) Sales in Volume by Application (2016-2026)
6.2 Global Gadobutrol (CAS 138071-82-6) Revenue by Application (2016-2026)
6.3 Global Gadobutrol (CAS 138071-82-6) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Gadobutrol (CAS 138071-82-6) Sales by Type (2016-2026)
7.2 North America Gadobutrol (CAS 138071-82-6) Sales by Application (2016-2026)
7.3 North America Gadobutrol (CAS 138071-82-6) Market Size by Country
7.3.1 North America Gadobutrol (CAS 138071-82-6) Sales in Volume by Country (2016-2026)
7.3.2 North America Gadobutrol (CAS 138071-82-6) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Gadobutrol (CAS 138071-82-6) Sales by Type (2016-2026)
8.2 Europe Gadobutrol (CAS 138071-82-6) Sales by Application (2016-2026)
8.3 Europe Gadobutrol (CAS 138071-82-6) Market Size by Country
8.3.1 Europe Gadobutrol (CAS 138071-82-6) Sales in Volume by Country (2016-2026)
8.3.2 Europe Gadobutrol (CAS 138071-82-6) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales by Type (2016-2026)
9.2 Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales by Application (2016-2026)
9.3 Asia-Pacific Gadobutrol (CAS 138071-82-6) Market Size by Region
9.3.1 Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Gadobutrol (CAS 138071-82-6) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Gadobutrol (CAS 138071-82-6) Sales by Type (2016-2026)
10.2 South America Gadobutrol (CAS 138071-82-6) Sales by Application (2016-2026)
10.3 South America Gadobutrol (CAS 138071-82-6) Market Size by Country
10.3.1 South America Gadobutrol (CAS 138071-82-6) Sales in Volume by Country (2016-2026)
10.3.2 South America Gadobutrol (CAS 138071-82-6) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Type (2016-2026)
11.2 Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Application (2016-2026)
11.3 Middle East & Africa Gadobutrol (CAS 138071-82-6) Market Size by Country
11.3.1 Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Gadobutrol (CAS 138071-82-6) Typical Distributors
12.3 Gadobutrol (CAS 138071-82-6) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Gadobutrol (CAS 138071-82-6) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Gadobutrol (CAS 138071-82-6) Revenue by Application, (USD Million), 2021-2026
Table 3. Bayer HealthCare Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Bayer HealthCare Pharmaceuticals Inc. Major Business
Table 5. Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Product and Services
Table 6. Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. SWAPNROOP DRUGS & PHARMACEUTICALS Basic Information, Manufacturing Base and Competitors
Table 8. SWAPNROOP DRUGS & PHARMACEUTICALS Major Business
Table 9. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Product and Services
Table 10. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Manus Aktteva Biopharma LLP Basic Information, Manufacturing Base and Competitors
Table 12. Manus Aktteva Biopharma LLP Major Business
Table 13. Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Product and Services
Table 14. Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Jilin Tely Imp & Exp CO.,LTD Basic Information, Manufacturing Base and Competitors
Table 16. Jilin Tely Imp & Exp CO.,LTD Major Business
Table 17. Jilin Tely Imp & Exp CO.,LTD Gadobutrol (CAS 138071-82-6) Product and Services
Table 18. Jilin Tely Imp & Exp CO.,LTD Gadobutrol (CAS 138071-82-6) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. JinYan Chemicals (ShangHai) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 20. JinYan Chemicals (ShangHai) Co., Ltd. Major Business
Table 21. JinYan Chemicals (ShangHai) Co., Ltd. Gadobutrol (CAS 138071-82-6) Product and Services
Table 22. JinYan Chemicals (ShangHai) Co., Ltd. Gadobutrol (CAS 138071-82-6) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. BOC Sciences Basic Information, Manufacturing Base and Competitors
Table 24. BOC Sciences Major Business
Table 25. BOC Sciences Gadobutrol (CAS 138071-82-6) Product and Services
Table 26. BOC Sciences Gadobutrol (CAS 138071-82-6) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. LGM Pharma Basic Information, Manufacturing Base and Competitors
Table 28. LGM Pharma Major Business
Table 29. LGM Pharma Gadobutrol (CAS 138071-82-6) Product and Services
Table 30. LGM Pharma Gadobutrol (CAS 138071-82-6) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Advanced Technology & Industrail Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 32. Advanced Technology & Industrail Co., Ltd. Major Business
Table 33. Advanced Technology & Industrail Co., Ltd. Gadobutrol (CAS 138071-82-6) Product and Services
Table 34. Advanced Technology & Industrail Co., Ltd. Gadobutrol (CAS 138071-82-6) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. MedKoo Biosciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 36. MedKoo Biosciences, Inc. Major Business
Table 37. MedKoo Biosciences, Inc. Gadobutrol (CAS 138071-82-6) Product and Services
Table 38. MedKoo Biosciences, Inc. Gadobutrol (CAS 138071-82-6) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Gadobutrol (CAS 138071-82-6) Sales by Manufacturer (2019-2021e) & (K MT)
Table 40. Global Gadobutrol (CAS 138071-82-6) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Gadobutrol (CAS 138071-82-6), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Gadobutrol (CAS 138071-82-6) Production Capacity by Company, (K MT): 2020 VS 2021
Table 43. Head Office and Gadobutrol (CAS 138071-82-6) Production Site of Key Manufacturer
Table 44. Global Gadobutrol (CAS 138071-82-6) Sales by Region (2016-2021e) & (K MT)
Table 45. Global Gadobutrol (CAS 138071-82-6) Sales by Region (2021-2026) & (K MT)
Table 46. Global Gadobutrol (CAS 138071-82-6) Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Gadobutrol (CAS 138071-82-6) Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Gadobutrol (CAS 138071-82-6) Sales by Type (2016-2021e) & (K MT)
Table 49. Global Gadobutrol (CAS 138071-82-6) Sales by Type (2021-2026) & (K MT)
Table 50. Global Gadobutrol (CAS 138071-82-6) Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Gadobutrol (CAS 138071-82-6) Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Gadobutrol (CAS 138071-82-6) Price by Type (2016-2021e) & (USD/MT)
Table 53. Global Gadobutrol (CAS 138071-82-6) Price by Type (2021-2026) & (USD/MT)
Table 54. Global Gadobutrol (CAS 138071-82-6) Sales by Application (2016-2021e) & (K MT)
Table 55. Global Gadobutrol (CAS 138071-82-6) Sales by Application (2021-2026) & (K MT)
Table 56. Global Gadobutrol (CAS 138071-82-6) Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Gadobutrol (CAS 138071-82-6) Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Gadobutrol (CAS 138071-82-6) Price by Application (2016-2021e) & (USD/MT)
Table 59. Global Gadobutrol (CAS 138071-82-6) Price by Application (2021-2026) & (USD/MT)
Table 60. North America Gadobutrol (CAS 138071-82-6) Sales by Country (2016-2021e) & (K MT)
Table 61. North America Gadobutrol (CAS 138071-82-6) Sales by Country (2021-2026) & (K MT)
Table 62. North America Gadobutrol (CAS 138071-82-6) Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Gadobutrol (CAS 138071-82-6) Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Gadobutrol (CAS 138071-82-6) Sales by Type (2016-2021e) & (K MT)
Table 65. North America Gadobutrol (CAS 138071-82-6) Sales by Type (2021-2026) & (K MT)
Table 66. North America Gadobutrol (CAS 138071-82-6) Sales by Application (2016-2021e) & (K MT)
Table 67. North America Gadobutrol (CAS 138071-82-6) Sales by Application (2021-2026) & (K MT)
Table 68. Europe Gadobutrol (CAS 138071-82-6) Sales by Country (2016-2021e) & (K MT)
Table 69. Europe Gadobutrol (CAS 138071-82-6) Sales by Country (2021-2026) & (K MT)
Table 70. Europe Gadobutrol (CAS 138071-82-6) Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Gadobutrol (CAS 138071-82-6) Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Gadobutrol (CAS 138071-82-6) Sales by Type (2016-2021e) & (K MT)
Table 73. Europe Gadobutrol (CAS 138071-82-6) Sales by Type (2021-2026) & (K MT)
Table 74. Europe Gadobutrol (CAS 138071-82-6) Sales by Application (2016-2021e) & (K MT)
Table 75. Europe Gadobutrol (CAS 138071-82-6) Sales by Application (2021-2026) & (K MT)
Table 76. Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales by Region (2016-2021e) & (K MT)
Table 77. Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales by Region (2021-2026) & (K MT)
Table 78. Asia-Pacific Gadobutrol (CAS 138071-82-6) Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Gadobutrol (CAS 138071-82-6) Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales by Type (2016-2021e) & (K MT)
Table 81. Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales by Type (2021-2026) & (K MT)
Table 82. Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales by Application (2016-2021e) & (K MT)
Table 83. Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales by Application (2021-2026) & (K MT)
Table 84. South America Gadobutrol (CAS 138071-82-6) Sales by Country (2016-2021e) & (K MT)
Table 85. South America Gadobutrol (CAS 138071-82-6) Sales by Country (2021-2026) & (K MT)
Table 86. South America Gadobutrol (CAS 138071-82-6) Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Gadobutrol (CAS 138071-82-6) Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Gadobutrol (CAS 138071-82-6) Sales by Type (2016-2021e) & (K MT)
Table 89. South America Gadobutrol (CAS 138071-82-6) Sales by Type (2021-2026) & (K MT)
Table 90. South America Gadobutrol (CAS 138071-82-6) Sales by Application (2016-2021e) & (K MT)
Table 91. South America Gadobutrol (CAS 138071-82-6) Sales by Application (2021-2026) & (K MT)
Table 92. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Country (2016-2021e) & (K MT)
Table 93. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Country (2021-2026) & (K MT)
Table 94. Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Type (2016-2021e) & (K MT)
Table 97. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Type (2021-2026) & (K MT)
Table 98. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Application (2016-2021e) & (K MT)
Table 99. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales by Application (2021-2026) & (K MT)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Gadobutrol (CAS 138071-82-6) Typical Distributors
Table 103. Gadobutrol (CAS 138071-82-6) Typical Customers
List of Figures
Figure 1. Gadobutrol (CAS 138071-82-6) Picture
Figure 2. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Type in 2020
Figure 3. Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
Figure 4. Single Dose Pre-filled Injections (7.5 mL, 10 mL, 15 mL)
Figure 5. Pharmacy Bulk Packages (30 mL and 65 mL)
Figure 6. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Application in 2020
Figure 7. Adults
Figure 8. Children
Figure 9. Global Gadobutrol (CAS 138071-82-6) Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 10. Global Gadobutrol (CAS 138071-82-6) Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Gadobutrol (CAS 138071-82-6) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Gadobutrol (CAS 138071-82-6) Sales (2016-2026) & (K MT)
Figure 31. Global Gadobutrol (CAS 138071-82-6) Production Capacity (2016-2026) & (K MT)
Figure 32. Global Gadobutrol (CAS 138071-82-6) Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Gadobutrol (CAS 138071-82-6) Market Drivers
Figure 34. Gadobutrol (CAS 138071-82-6) Market Restraints
Figure 35. Gadobutrol (CAS 138071-82-6) Market Trends
Figure 36. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Manufacturer in 2020
Figure 37. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Manufacturer in 2020
Figure 38. Gadobutrol (CAS 138071-82-6) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Gadobutrol (CAS 138071-82-6) Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Gadobutrol (CAS 138071-82-6) Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Region (2016-2026)
Figure 42. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Region (2016-2026)
Figure 43. North America Gadobutrol (CAS 138071-82-6) Revenue (2016-2026) & (USD Million)
Figure 44. Europe Gadobutrol (CAS 138071-82-6) Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Gadobutrol (CAS 138071-82-6) Revenue (2016-2026) & (USD Million)
Figure 46. South America Gadobutrol (CAS 138071-82-6) Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue (2016-2026) & (USD Million)
Figure 48. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2016-2026)
Figure 49. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Type (2016-2026)
Figure 50. Global Gadobutrol (CAS 138071-82-6) Price by Type (2016-2026) & (USD/MT)
Figure 51. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2016-2026)
Figure 52. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Application (2016-2026)
Figure 53. Global Gadobutrol (CAS 138071-82-6) Price by Application (2016-2026) & (USD/MT)
Figure 54. North America Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2016-2026)
Figure 55. North America Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2016-2026)
Figure 56. North America Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2016-2026)
Figure 57. North America Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2016-2026)
Figure 58. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2016-2026)
Figure 59. Europe Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2016-2026)
Figure 60. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2016-2026)
Figure 61. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Gadobutrol (CAS 138071-82-6) Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2016-2026)
Figure 66. South America Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2016-2026)
Figure 67. South America Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2016-2026)
Figure 68. South America Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2016-2026)
Figure 69. South America Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source